Press Releases

Year

Nov 2008

New Study Proves Protandim® Produces 300% Increase in Glutathione, a Key Antioxidant and Anti-aging Factor

Synergistic Formulation Provides Body with Thousands of Times More Antioxidant Power than Any Food or Conventional Supplements

PDF Version

Nov 2008

LifeVantage Corporation Announces 1Q FY 2009 Financial and Operating Results

LifeVantage Corporation Announces 1Q FY 2009 Financial and Operating Results LifeVantage Corporation (OTCBB: LFVN) , maker of Protandim ® , today announced results for its first quarter ended September 30, 2008. For the three month period ended September 30, 2008, the Company recorded net revenues

PDF Version

Oct 2008

LifeVantage Announces Launch of Protandim® Into Multi-Billion Dollar Network Marketing Sales Channel

LifeVantage Announces Launch of Protandim(R) Into Multi-Billion Dollar Network Marketing Sales Channel Protandim ® ( www.Protandim.com ), the only product clinically proven to slow the progressive rate of aging, announced today that it is entering the multi-billion dollar network marketing industry

PDF Version

Oct 2008

Carlon M. Colker, M.D., FACN, Nationally Renowned Medical Expert in the Areas of Wellness, Physical Performance and Performance Nutrition, Joins LifeVantage Corporation Scientific Advisory Board

Carlon M. Colker, M.D., FACN, Nationally Renowned Medical Expert in the Areas of Wellness, Physical Performance and Performance Nutrition, Joins LifeVantage Corporation Scientific Advisory Board LifeVantage Corporation (OTCBB:LFVN), the maker of Protandim ® , the only product clinically proven to

PDF Version

Oct 2008

LifeVantage Corporation Schedules 4th Quarter and FY 2008 Conference Call

SAN DIEGO--(BUSINESS WIRE)-- LifeVantage Corporation (OTCBB LFVN - News) , maker of Protandim ® , will hold a conference call on October 7, 2008 at 10:00 a.m. PT (1:00 p.m. ET) to discuss its fourth quarter and fiscal year 2008 financial and operating results.

PDF Version

Sep 2008

LifeVantage Corporation Announces Q4 and FY 2008 Financial and Operating Results

LifeVantage Corporation Announces Q4 and FY 2008 Financial and Operating Results SAN DIEGO--(BUSINESS WIRE)-- LifeVantage Corporation (OTCBB: LFVN- News) , maker of Protandim ® , today announced results for its year ended June 30, 2008. The Company recorded net revenues of $3.2 million and a net

PDF Version

Sep 2008

LifeVantage Corporation Invited to Present at EdgeWater Research Small/Micro Cap Conference September 24th and 25th, 2008

LifeVantage Corporation Invited to Present at EdgeWater Research Small/Micro Cap Conference September 24th and 25th, 2008 LifeVantage Corporation (OTCBB: LFVN) , the maker of Protandim ® , the only product clinically proven to slow the progressive rate of aging, today announced that the senior

PDF Version

Aug 2008

LifeVantage Corporation, Maker of Protandim(R), Joins Forces with Cornerstone R&D, Inc. to Dramatically Cut Manufacturing Costs

LifeVantage Corporation, Maker of Protandim(R), Joins Forces with Cornerstone R&D, Inc. to Dramatically Cut Manufacturing Costs LifeVantage Corporation (OTCBB:LFVN) , the maker of Protandim ® , the only product clinically proven to slow the progressive rate of aging, announced the company has

PDF Version

Aug 2008

LifeVantage Corporation Posts Record Unique Visitors & Page Views for Protandim.com

New Internet Customer Acquisition Reaches Highest Level in Three Years

PDF Version

Aug 2008

LifeVantage Corporation Announces Increased Sales Distribution for Protandim(R)

LifeVantage Corporation Announces Increased Sales Distribution for Protandim(R) LifeVantage Corporation (OTCBB: LFVN) has announced it has increased distribution of Protandim ® ( www.protandim.com ) via a network of well-known regional brokers; the initiation of a direct sales program to healthcare

PDF Version

Pagination

First page
Previous page
…
Page 33
Page 34
Page 35
Page 36
Current page 37
Page 38
Page 39
Page 40
Page 41
…
Next page
Last page